Heart device study reveals clotting protein changes
NCT ID NCT02628509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how certain heart devices change a blood-clotting protein called von Willebrand factor. Researchers studied 500 adults with heart failure or aortic stenosis who received a mechanical heart pump or a valve replacement. The goal was to understand when these protein changes start and stop, and how they relate to patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lille University Hospital
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could delaying kidney implant during heart transplant reduce complications?
- A simple conversation could change how heart failure patients care for themselves
- A picture-based lesson may help heart failure patients spot trouble early
- Can a Two-Drug punch early in hospitalization tame heart failure?
- Bedside flu shot for heart patients: a simple strategy to save lives?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.